Form D · Biotechnology
Poseida Therapeutics, Inc.
San Diego, CA · CIK 0001661460
Offering snapshot reported Aug 11, 2023 · SEC filing
- Reported sold
- $25M Offering amount: $25M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 7, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 11, 2023 | Initial | $24,999,999 | No comparison | 1 | SEC filing |
| Apr 22, 2019 | Initial | $142,120,007 | No comparison | 17 | SEC filing |
| Apr 3, 2018 | Initial | $30,499,990 | No comparison | 7 | SEC filing |
| Aug 3, 2017 | Initial | $11,160,002 | No comparison | 16 | SEC filing |
| Dec 24, 2015 | Initial | $23,033,232 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-489546
Source: Form D, filed Aug 11, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rafael Amado | Director |
| Charles M. Baum | Director |
| Noah Berkowitz | Director |
| Cynthia Collins | Director |
| Luke Corning | Director |
| Nishan De Silva | Director, Executive |
| Lars Ekman | Director |
| Mark J. Gergen | Director, Executive |
| David Hirsch | Director |
| Adrian Howd | Director |
| Harry J. Leonhardt | Executive |
| Marcea B. Lloyd | Director |
| Robert Lyons | Director |
| Catherine J. Mackey | Director |
| Sean Murphy | Director |
| Johanna M. Mylet | Executive |
| Eric Ostertag | Director, Executive |
| John Schmid | Director |
| Matthew Spear | Executive |
| Brent Warner | Executive |
| Kristin Yarema | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9390 Towne Centre Drive Suite 200
San Diego, CA, 92121
San Diego, CA, 92121